RNAZ   $3.25  -4.41% Market Open

Transcode Therapeutics Inc
Total Cash 3.35M
totalCashPerShare 0.194
EBITDA -17.68M
Total Debt 227.25K
quickRatio 0.958
currentRatio 1.252
Total Revenue
debtToEquity 17.186
Revenue/Share
ROA -2.0795
ROE -10.48698
grossProfits
freeCashflow -8.54M
operatingCashflow -15.45M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 4.97M
forwardPE -0.78166664
floatShares 17.26M
sharesOutstanding 17.27M
sharesShort 1.22M
sharesShortPriorMonth 904.67K
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.12%
Short Ratio help_outline 0.38%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 0.182
Price To Book help_outline 2.58
earningsQuarterlyGrowth
netIncomeToCommon -17.91M
trailingEps 241.16%
forwardEps -0.60%
enterpriseToEbitda -0.28
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.49 3Q 2024
institutionsCount 16
lastUpdated Nov. 7, 2024, 5:01 a.m.